New Phase I drug structure by Bristol-Myers Squibb disclosed at the spring 2013 American Chemical Society meeting in New Orleans to treat breast lung and colon cancers and leukemia. The drug works as an pan-Notch inhibitor. The structure is one of a set patented in 2012 and it currently being studied in clinical trials.
This page contains content from the copyrighted Wikipedia article "BMS-906024"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
